Table 5.
Treatment | FDA Classification a | Recommended us in SLE pregnancy |
---|---|---|
Prenatal Multivitamin | A | All women |
Acetaminophen | A | As needed for pain control |
NSAID | B 1st & 2nd trimesters. D 3rd trimester | As needed for pain control in the latter 1st trimester and 2nd trimester only. Discontinue in 3rd trimester. |
Prednisone & Prednisolone | B | As needed to control lupus activity. |
Dexamethasone & Betamethasone | C | Not for treatment of lupus. As needed to treat the fetus. |
Hydroxychloroquine | C | For all women if on prior to pregnancy or to treat mild flares in pregnancy |
IVIg | C | As needed to control lupus activity. |
Mycophenolate mofetil | C | Only if no other options |
Azathioprine | D | Continue if on prior to pregnancy. May help treat flares. |
Cyclophosphamide | D | Only if no other options |
Methotrexate | X | No use |
Leflunomide | X | No use |
FDA pregnancy risk categories: A, no risk in controlled clinic trials of humans; B, human data reassuring or when absent, animal studies show no risk; C, human data are lacking and animal studies show risk or are not done; D, positive evidence of risk but the benefit may outweigh the risks; X, contraindicated in pregnancy.